Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni
Jaspreet Toor, Hugo C. Turner, James E. Truscott, et al.
PLoS neglected tropical diseases (2018) Vol. 12, Iss. 10, pp. e0006717-e0006717
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Prevalence and distribution of schistosomiasis in human, livestock, and snail populations in northern Senegal: a One Health epidemiological study of a multi-host system
Elsa Léger, Anna Borlase, Cheikh Binetou Fall, et al.
The Lancet Planetary Health (2020) Vol. 4, Iss. 8, pp. e330-e342
Open Access | Times Cited: 120
Schistosomiasis Control: Leave No Age Group Behind
Christina L. Faust, Derick Nii Mensah Osakunor, Jennifer A. Downs, et al.
Trends in Parasitology (2020) Vol. 36, Iss. 7, pp. 582-591
Open Access | Times Cited: 91
The prevalence of schistosomiasis in Uganda: A nationally representative population estimate to inform control programs and water and sanitation interventions
Natalie G. Exum, Simon P. S. Kibira, Ronald Ssenyonga, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 8, pp. e0007617-e0007617
Open Access | Times Cited: 72
Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis
Diepreye Ayabina, Jessica Clark, Helena Bayley, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 11, pp. e0009083-e0009083
Open Access | Times Cited: 53
Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa
Charles H. King, Nupur Kittur, Sue Binder, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 103, Iss. 1_Suppl, pp. 14-23
Open Access | Times Cited: 48
Scoping review of Neglected Tropical Disease Interventions and Health Promotion: A framework for successful NTD interventions as evidenced by the literature
Caroline Ackley, Mohamed A. El‐Sheikh, Shahaduz Zaman
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 7, pp. e0009278-e0009278
Open Access | Times Cited: 38
Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
Klodeta Kura, Diepreye Ayabina, Jaspreet Toor, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 115, Iss. 3, pp. 236-244
Open Access | Times Cited: 36
Associations of water contact frequency, duration, and activities with schistosome infection risk: A systematic review and meta-analysis
Fabian Reitzug, Julia Ledien, Goylette F. Chami
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 6, pp. e0011377-e0011377
Open Access | Times Cited: 13
Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
Klodeta Kura, James E. Truscott, Jaspreet Toor, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 6, pp. e0007349-e0007349
Open Access | Times Cited: 37
Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
Jaspreet Toor, David Rollinson, Hugo C. Turner, et al.
The Journal of Infectious Diseases (2019) Vol. 221, Iss. Supplement_5, pp. S525-S530
Open Access | Times Cited: 37
How Does Treatment Coverage and Proportion Never Treated Influence the Success of Schistosoma mansoni Elimination as a Public Health Problem by 2030?
Klodeta Kura, Nyamai Mutono, María‐Gloria Basáñez, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. Supplement_2, pp. S126-S130
Open Access | Times Cited: 4
Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis
Luc E. Coffeng, Matthew Graham, Raiha Browning, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. Supplement_2, pp. S153-S159
Open Access | Times Cited: 3
The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
Klodeta Kura, Robert J. Hardwick, James E. Truscott, et al.
Parasites & Vectors (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Helminthiasis Epidemiology and Control
Charles H. King
Advances in Parasitology/Advances in parasitology (2018), pp. 11-30
Closed Access | Times Cited: 23
Negative Association of Interleukin-33 Plasma Levels and Schistosomiasis Infection in a Site of Polyparasitism in Rural Cameroon
Séverin Donald Kamdem, Francis Konhawa, Erve Martial Kuemkon, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 22
Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission
Jaspreet Toor, James E. Truscott, Marleen Werkman, et al.
Parasites & Vectors (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Age-group associations of schistosomiasis prevalence from trial data, Côte d’Ivoire, Kenya and the United Republic of Tanzania
Ryan E. Wiegand, Maurice R. Odiere, Safari Kinung’hi, et al.
Bulletin of the World Health Organization (2024) Vol. 102, Iss. 04, pp. 265-275
Open Access | Times Cited: 2
Re-assessment of schistosomiasis in nine endemic districts with cluster sampling in Sierra Leone
Ibrahim Kargbo-Labour, Victoria Redwood-Sawyerr, Abdulai Conteh, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
Vaccine value profile for schistosomiasis
Gavin Yamey, Kaci Kennedy McDade, Roy M. Anderson, et al.
Vaccine (2024), pp. 126020-126020
Open Access | Times Cited: 2
Economic evaluations of human schistosomiasis interventions: a systematic review and identification of associated research needs
Hugo C. Turner, Michael D. French, Antonio Montresor, et al.
Wellcome Open Research (2020) Vol. 5, pp. 45-45
Open Access | Times Cited: 17
Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
Klodeta Kura, Benjamin Collyer, Jaspreet Toor, et al.
Vaccine (2020) Vol. 38, Iss. 28, pp. 4379-4386
Open Access | Times Cited: 17
Economic evaluations of human schistosomiasis interventions: a systematic review and identification of associated research needs
Hugo C. Turner, Michael D. French, Antonio Montresor, et al.
Wellcome Open Research (2020) Vol. 5, pp. 45-45
Open Access | Times Cited: 17
School-based preventive chemotherapy program for schistosomiasis and soil-transmitted helminth control in Angola: 6-year impact assessment
Adam Bartlett, Elsa P. Mendes, Latifeh Dahmash, et al.
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 5, pp. e0010849-e0010849
Open Access | Times Cited: 6
Differential impact of mass and targeted praziquantel delivery on schistosomiasis control in school-aged children: A systematic review and meta-analysis
Danielle M. Cribb, Naomi E. Clarke, Suhail A.R. Doi, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 10, pp. e0007808-e0007808
Open Access | Times Cited: 17
Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison
Benjamin Collyer, Hugo C. Turner, T. Déirdre Hollingsworth, et al.
Parasites & Vectors (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top